WO2000047190A2 - Method for producing film-type dosage forms - Google Patents

Method for producing film-type dosage forms Download PDF

Info

Publication number
WO2000047190A2
WO2000047190A2 PCT/EP2000/000739 EP0000739W WO0047190A2 WO 2000047190 A2 WO2000047190 A2 WO 2000047190A2 EP 0000739 W EP0000739 W EP 0000739W WO 0047190 A2 WO0047190 A2 WO 0047190A2
Authority
WO
WIPO (PCT)
Prior art keywords
film
drying
dosage forms
drying phase
producing film
Prior art date
Application number
PCT/EP2000/000739
Other languages
German (de)
French (fr)
Other versions
WO2000047190A3 (en
Inventor
Michael Horstmann
Wolfgang Laux
Horst Dzekan
Katja Zinndorf
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL14476700A priority Critical patent/IL144767A0/en
Priority to BRPI0009962-7A priority patent/BR0009962B1/en
Priority to NZ513465A priority patent/NZ513465A/en
Priority to AU31514/00A priority patent/AU777898B2/en
Priority to MXPA01007867A priority patent/MXPA01007867A/en
Priority to JP2000598143A priority patent/JP2002536402A/en
Priority to HU0202877A priority patent/HUP0202877A2/en
Priority to CA002362756A priority patent/CA2362756C/en
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Priority to EP00909123A priority patent/EP1150663A2/en
Publication of WO2000047190A2 publication Critical patent/WO2000047190A2/en
Publication of WO2000047190A3 publication Critical patent/WO2000047190A3/en
Priority to IL144767A priority patent/IL144767A/en
Priority to NO20013892A priority patent/NO20013892L/en
Priority to HK02100760.6A priority patent/HK1039069A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/79Fixation, conservation, or encapsulation of flavouring agents in the form of films
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/20Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to film-like dosage forms for use as cosmetic, pharmaceutical or food products.
  • EP 0 216 762 presents a water-soluble film made of starch, gelatin, glycerin or sorbitol, which is coated by means of a roller application process. It is mentioned briefly that such dosage forms can also be produced for chemical reagents, flavorings and the like.
  • a formulation that is fundamentally suitable for the production of film-shaped systems is presented in EP 0 460 588.
  • particular advantages are seen in the composition of 20 to 60 percent by weight film former, 2 to 40% gel former, 0.1 to 35 percent by weight of active ingredient (here: flavoring) and a maximum of 40 percent by weight of an inert filler.
  • DE 36 30 603 sees particular advantages in designing the flat dosage form on a carrier material (separating film) in a dose-wise manner.
  • the object of this invention is to provide processes for the production of sheet-like active substance carriers which enable an exact and reproducible coating quality, prevent the finally produced film pieces from adhering to one another in the stack and avoid contamination and too high heat loads are available at high process speeds.
  • the object is achieved according to the present invention in that the coating of the solution of hydrophilic polymers with added active ingredients and other auxiliaries is immediately followed by an overflow of moderately warm (30-50 ° C.) air, then the temperature is slightly increased (35 -80 ° C), followed by a reconditioning phase at 25-50 ° C.
  • the process speed is advantageously regulated in such a way that a relative substrate moisture (equivalent moisture or equivalent air humidity) of 50-75% RH, preferably 60-68% RH, is not left in any case.
  • the method according to the invention can be applied to any form of sheet-like products, for example for use as food, pharmaceuticals or cosmetics, which in a coating process consist of a solvent, in particular re water, liquefied mass, which contains solid, hydrophilic raw materials and optionally further components, can be produced.
  • Suitable substances are, for example, carbonates, phosphates, silicates, or sulfates of alkaline earth metals, zinc oxide, titanium dioxide or other color pigments, talc, lactose, cyclodextrins or starch and starch derivatives, provided that they form their own, solid, disperse phase in the end product.
  • Aromas which can be used with this invention are essentially essential oils (volatile, water-insoluble distillates from fragrant plant components) and other volatile, fragrant substances which have a limited miscibility with water.
  • the mass is obtained, for example, by sprinkling, kneading or slowly digesting the solid components in the solvent (usually water, but also, for example, ethanol, Acetone and other compatible, physiologically acceptable solvents and their mixtures are used). If contained in the recipe, the pre-weighed amount of flavoring and other liquid, lipophilic additives are added to this phase with slow stirring. In the interest of the objective of the invention, it has proven to be very advantageous with regard to a more uniform nature to homogenize the mass before coating via a high-speed homogenizer.
  • the solvent usually water, but also, for example, ethanol, Acetone and other compatible, physiologically acceptable solvents and their mixtures are used.
  • the mass is coated onto a substrate by brushing, knife coating or extrusion processes and is dried in a drying channel consisting of at least three independently temperature-controlled zones.
  • the substrate can in principle be made from substrates known to those skilled in the art and widely used, e.g. Polyethylene terephthalate, polyethylene, polypropylene, polycarbonate, polyurethane exist. Laminates of these materials with other polymers, paper, glass fibers and other structure formers are also used to increase the tear resistance. Measures such as siliconization, fluorination, acid treatment or corona treatment can be useful to regulate the surface adhesion, but in individual cases they need to be clarified as to their physiological compatibility for the respective application.
  • the aim of the invention is regularly achieved when the drying with initially increasing, at the latest in in the last zone then process temperature reduced by 10 ° C again.
  • the process speed is advantageously set so that a product with an equivalent air humidity of 50-75% RH, preferably 60-68% RH, is obtained.
  • the products obtained proved to be surface-stable, flexible and unbreakable and largely tear-resistant.
  • the resulting surfaces have practically no "cold flow", so they are basically dimensionally stable.
  • the film can be removed from the base without noticeable stretching and processed separately.
  • the film-shaped products produced preferably have a thickness between 20 and 300 ⁇ m; their size can advantageously be 0.5 to 12 cm 2 .
  • the subsequent packaging can be done individually or in a stack, for example in sealed bags or dispensers.

Abstract

The invention relates to a method for producing film-type dosage forms by applying a coating of a spreadable mass containing a solvent on a substrate and drying. The invention is characterised in that the drying process is carried out in a first drying phase between 30 and 50 °C, in a second drying phase between 35 and 80 °C and in a third drying phase between 25 and 50 °C.

Description

Verfahren zur Herstellung folienförπ-iger DarreichungsformenProcess for the production of film-like dosage forms
Die vorliegende Erfindung betrifft folienförmige Darreichungsformen zur Anwendung als kosmetische, pharmazeutische oder lebens itteltechnische Produkte.The present invention relates to film-like dosage forms for use as cosmetic, pharmaceutical or food products.
Im Mundbereich und auf den Schleimhäuten des Mundes anzuwendende flächige Darreichungsformen sind bekannt. So beschreibt bereits US 3 444 858 (Russell, 1969) Medikamentstreifen auf Basis eines gelatineartigen Materials.Flat dosage forms to be used in the mouth area and on the mucous membranes of the mouth are known. No. 3,444,858 (Russell, 1969) already describes medicament strips based on a gelatin-like material.
In EP 0 216 762 wird eine wasserlösliche Folie aus Stärke, Gelatine, Glycerin oder Sorbit vorgestellt, die mittels eines Walzenauftragsverfahrens beschichtet wird. Es wird dabei kurz erwähnt, daß sich solche Dosierungsformen auch für chemische Reagenzien, Aromastoffe und dergleichen herstellen lassen.EP 0 216 762 presents a water-soluble film made of starch, gelatin, glycerin or sorbitol, which is coated by means of a roller application process. It is mentioned briefly that such dosage forms can also be produced for chemical reagents, flavorings and the like.
Eine zur Herstellung folienförmiger Systeme grundsätzlich geeignete Formulierung wird in EP 0 460 588 vorgestellt. Hier werden besondere Vorteile in der Zusammensetzung aus 20 bis 60 Gewichtsprozent Filmbildner, 2 bis 40 % Gelbild- ner, 0,1 bis 35 Gewichtsprozent Wirkstoff (hier: Aromastoff) und maximal 40 Gewichtsprozent eines inerten Füllstoffes gesehen.A formulation that is fundamentally suitable for the production of film-shaped systems is presented in EP 0 460 588. Here, particular advantages are seen in the composition of 20 to 60 percent by weight film former, 2 to 40% gel former, 0.1 to 35 percent by weight of active ingredient (here: flavoring) and a maximum of 40 percent by weight of an inert filler.
DE 36 30 603 sieht besondere Vorteile darin, die flächige Dosierungsform auf einem Trägermaterial (Trennfilm) dosisweise abziehbar zu gestalten.DE 36 30 603 sees particular advantages in designing the flat dosage form on a carrier material (separating film) in a dose-wise manner.
US 4 128 445 und 4 197 289 (Sturzenegger, 1978) gehen auf mögliche technische Lösungen bei der Beladung mit Wirkstoffen ein. Für arzneimittelhaltige folienför ige Systeme werden auch Vorteile in einem zweischichtigen Aufbau aus einer wasser- quellbaren Schicht und einem wasserunlöslichen Barrierefilm gesehen (US 5 047 244) .US 4 128 445 and 4 197 289 (Sturzenegger, 1978) deal with possible technical solutions when loading with active substances. For drug-containing film-shaped systems, advantages are also seen in a two-layer structure consisting of a water-swellable layer and a water-insoluble barrier film (US Pat. No. 5,047,244).
Einige hydrophile Filmbildner, insbesondere Pullulan und andere Glucane, aber auch Cellulosederivate weisen bei der Herstellung solcher Filme mangelhafte Benetzung auf üblichen Beschichtungsmedien auf. Die Folge kann vorzeitige oder schwierige Substratablösung sowie ungleichmäßige resultierende Foliendicke sein. Zur Abhilfe empfiehlt US 4 562 020 die Verwendung eines im Prozeß als Schlaufe umlaufenden Substrates auf Basis unpolarer hitzestabiler Polymere, welches innerhalb des Prozesses ständig einer oberflächigen Korona-Behandlung unterzogen wird und damit ständig neu eine ausreichend sicher benetzende, polare Oberfläche erhält. Es wird bei Trocknungstemperaturen zwischen 40 und 110 °C gearbeitet; in den Beispielen finden sich Temperaturen zwischen 60 und 85 °C.Some hydrophilic film formers, in particular pullulan and other glucans, but also cellulose derivatives, have inadequate wetting on conventional coating media in the production of such films. The consequence can be premature or difficult substrate detachment and uneven resulting film thickness. To remedy this, US Pat. No. 4,562,020 recommends the use of a substrate rotating in the process as a loop on the basis of non-polar, heat-stable polymers, which is constantly subjected to a surface corona treatment during the process and thus constantly receives a sufficiently securely wetting, polar surface. It works at drying temperatures between 40 and 110 ° C; In the examples there are temperatures between 60 and 85 ° C.
Als nachteilig erweisen sich die auf den beschriebenen reinen Foliensubstraten hergestellten Aroma-Folien wegen ihrer beidseitigen Glätte. Solche Produkte eignen sich nur eingeschränkt zur Weiterverarbeitung und Anwendung in durch Fo- lienschnitt gebildeten Stapeln. Solche Stapel von Folienstücken oder -stanzlingen, wie sie zur Anwendung beim Verbraucher häufig in geeigneten Dosierspendern angeboten werden, neigen zur gegenseitigen Verklebung, die eine sichere Entnahme stark erschwert. Da solche folienförmigen Darreichungsformen wegen ihres geringen Flächengewichtes (typisch ca. 10 bis 80 g/m2 ) zu statischer Aufladung neigen und die Oberflächen gleichzeitig wegen der späteren leichteren Entnahme gegeneinander verschiebbar ausgeführt sind, ist dieser Aspekt nicht nur bei der Verwendung, sondern auch bei der Prozeßtechnologie störend. Eine dritte Anforderung an den Prozeß ist die Vermeidung von hitzebedingten Aromaverlusten bei maximaler Prozeßgeschwindigkeit, für die sich auch aus dem Stand der Technik keine Hinweise ergeben.The aroma films produced on the described pure film substrates prove to be disadvantageous because of their smoothness on both sides. Such products are only of limited suitability for further processing and use in stacks formed by foil cutting. Such stacks of pieces of film or die cuts, as are often offered in suitable dosing dispensers for use by the consumer, tend to stick to one another, which makes safe removal very difficult. Since such film-like dosage forms tend to be statically charged due to their low basis weight (typically approx. 10 to 80 g / m 2 ) and the surfaces are designed to be displaceable relative to one another because of the later easier removal, this aspect is not only in use but also in the process technology disruptive. A third requirement for the process is the avoidance of heat-related loss of aroma at maximum process speed, for which there are no indications from the prior art either.
Aus diesen bisher im Stand der Technik nicht gelösten Anforderungen ergibt sich die Aufgabe dieser Erfindung, Verfahren zur Herstellung flächenförmiger Wirkstoffträger bereitszustellen, welche eine genaue und reproduzierbare Be- schichtungsgüte ermöglichen, die Anhaftung der final hergestellten Folienstücke aneinander im Stapel verhindern und unter Vermeidung von Kontamination und allzu hoher Hitzebelastung mit hoher Prozeßgeschwindigkeit erhältlich sind.From these requirements which have not yet been solved in the prior art, the object of this invention is to provide processes for the production of sheet-like active substance carriers which enable an exact and reproducible coating quality, prevent the finally produced film pieces from adhering to one another in the stack and avoid contamination and too high heat loads are available at high process speeds.
Die Aufgabe wird gemäß der vorliegenden Erfindung dadurch gelöst, daß sich an die Beschichtung der Lösung hydrophiler Polymere mit zugesetzten Wirk- und weiteren Hilfsstoffen unmittelbar eine Überströmung mit mäßig warmer (30-50°C) Luft anschließt, sodann die Temperatur leicht erhöht wird (35-80°C), worauf sich zuletzt eine Rekonditionierungsphase bei 25-50°C anschließt. Die Prozeßgeschwindigkeit wird dabei vorteilhaft so einreguliert, daß in jedem Fall eine relative Substratfeuchte (Äquivalentfeuchte oder äquivalente Luftfeuchte) von 50-75% r.F., bevorzugt 60-68% r.F., nicht verlassen wird.The object is achieved according to the present invention in that the coating of the solution of hydrophilic polymers with added active ingredients and other auxiliaries is immediately followed by an overflow of moderately warm (30-50 ° C.) air, then the temperature is slightly increased (35 -80 ° C), followed by a reconditioning phase at 25-50 ° C. The process speed is advantageously regulated in such a way that a relative substrate moisture (equivalent moisture or equivalent air humidity) of 50-75% RH, preferably 60-68% RH, is not left in any case.
Durch Verwendung oberflächenrauher Substrate, bevorzugt von Thermoplasten aus Polypropylen, Polyethylen, Polyethylen- terephthalat, Polycarbonat und Laminaten dieser Polymere, besonders bevorzugt polyethylenbeschichtetem Papier, wird eine Verklebung der später hergestellten Folieneinzelstücke im Stapel wirksam vermieden.By using substrates with a rough surface, preferably thermoplastics made of polypropylene, polyethylene, polyethylene terephthalate, polycarbonate and laminates of these polymers, particularly preferably polyethylene-coated paper, sticking of the individual film pieces produced later is effectively avoided in the stack.
Das erfindungsgemäße Verfahren ist auf jede Form flächenförmiger Produkte zum Beispiel zum Einsatz als Lebensmittel, Arzneimittel oder Kosmetikum anwendbar, die in einem Beschichtungsprozeß aus einer durch Lösemittel, insbesonde- re Wasser, verflüssigten Masse, die feste, hydrophile Grundstoffe und optional weitere Bestandteile enthält, herstellbar sind.The method according to the invention can be applied to any form of sheet-like products, for example for use as food, pharmaceuticals or cosmetics, which in a coating process consist of a solvent, in particular re water, liquefied mass, which contains solid, hydrophilic raw materials and optionally further components, can be produced.
Diese hydrophilen Grundstoffe können Polymere wie Stärke und ihre Derivate, Agar-Agar, Gelatine, Cellulose und Cel- lulosederivate, Alginsäure, Galactomannan, Carrageen, andere für das jeweilige Einsatzgebiet zulässige pflanzliche Gummen, Pullulan und andere Glucane, Dextran, Polyvinylpyr- rolidon-, Polyvinylalkohol- oder Polyacrylsäure-Ho o- und -copolymere sein. Der verwendete Polyvinylalkohol ist vorteilhafterweise eine teilhydrodysierte Form, bei der zwischen 1 und 20%, besonders bevorzugt ca. 12% der Hydroxylgruppen durch Acetylgruppen ersetzt sind.These hydrophilic raw materials can include polymers such as starch and their derivatives, agar-agar, gelatin, cellulose and cellulose derivatives, alginic acid, galactomannan, carrageenan, other vegetable gums permissible for the respective field of application, pullulan and other glucans, dextran, polyvinylpyrrolidone, Polyvinyl alcohol or polyacrylic acid ho o and copolymers. The polyvinyl alcohol used is advantageously a partially hydrodysed form in which between 1 and 20%, particularly preferably approximately 12%, of the hydroxyl groups are replaced by acetyl groups.
Das erfindungsgemäße Verfahren wirkt sich insbesondere bei problematischen Massen aus, die hohe Anteile an Pullulan, Carrageen oder Cellulosestern enthalten.The method according to the invention has an effect in particular in the case of problematic compositions which contain high proportions of pullulan, carrageenan or cellulose esters.
Hydrophile Zusätze geringen Molekulargewichts können als Strukturbildner ebenfalls eingesetzt werden; sie erfüllen meist anwendungsspezifische Ziele. Hier kommen u.a. Zucker, Zuckeralkohole, Zuckerersatzstoffe, organische Säuren, Po- lyethylenglycol infrage.Hydrophilic additives of low molecular weight can also be used as structure formers; they mostly meet application-specific goals. Here come Sugar, sugar alcohols, sugar substitutes, organic acids, polyethylene glycol in question.
Auch feste Stoffe, die wegen geringer Löslichkeit keine molekulardisperse Mischung oder Lösung im Grundmaterial eingehen, können enthalten sein. Geeignete Substanzen sind zum Beispiel Carbonate, Phosphate, Silicate, oder Sulfate der Erdalkalimetalle, Zinkoxid, Titandioxid oder andere Farbpigmente, Talkum, Lactose, Cyclodextrine oder Stärke und Stärkederivate, sofern sie im Endprodukt eine eigene, feste disperse Phase bilden.It can also contain solid substances that do not form a molecularly disperse mixture or solution in the base material due to their low solubility. Suitable substances are, for example, carbonates, phosphates, silicates, or sulfates of alkaline earth metals, zinc oxide, titanium dioxide or other color pigments, talc, lactose, cyclodextrins or starch and starch derivatives, provided that they form their own, solid, disperse phase in the end product.
Die vorstehende Auflistung ist beispielhaft und kann durch dem Fachmann bekannte funktionsgleiche Stoffe ergänzt werden. Wirkkomponenten können zum Beispiel arzneiliche oder kosmetische Wirkstoffe, diätetische Zusatzstoffe zu Lebensmitteln, Farbstoffe oder Diagnostika sein. Insbesondere ist der erfindungsgemäße Prozeß bei den sonst wegen ihrer Flüchtigkeit schwer verarbeitbaren Aromastoffen anwendbar. Bei mit dieser Erfindung einsetzbaren Aromen handelt es sich im wesentlichen um ätherische Öle (flüchtige, wasserunlösliche Destillate aus duftenden Pflanzenbestandteilen) und andere flüchtige, duftende Substanzen, die eine begrenzte Mischbarkeit mit Wasser aufweisen. Beispielhaft seien hier z.B. Phenylethanol als Bestandteil von Rosen- duftaro en, Menthol, Eucalyptol (Cineol), Camphen und Pinen in pfefferminzartig-frischen Aromen, appetitanregende Aromastoffe (Gewürzaromen) wie z.B. n-Butylphthalid oder Cineol, aber auch Aromastoffe mit arzneilicher Anwendung wie Eukalyptus- und Thymianöl, Methylsalicylat, Terpentinöl und Kamillenöl genannt.The above list is exemplary and can be supplemented by substances of the same function known to the person skilled in the art. Active components can be, for example, medicinal or cosmetic active ingredients, dietary additives to foods, dyes or diagnostics. In particular, the process according to the invention is applicable to the aroma substances which are otherwise difficult to process because of their volatility. Aromas which can be used with this invention are essentially essential oils (volatile, water-insoluble distillates from fragrant plant components) and other volatile, fragrant substances which have a limited miscibility with water. Examples include, for example, phenylethanol as a component of rose fragrances, menthol, eucalyptol (cineol), camphene and pinene in peppermint-like aromas, appetizing aroma substances (spice aromas) such as n-butyl phthalide or cineol, but also aroma substances with medicinal use such as eucalyptus - And called thyme oil, methyl salicylate, turpentine oil and chamomile oil.
Ein sehr weites Feld nehmen Essenzen und Aromen ein, die als Zusätze für Lebensmittel und in vorgefertigten Lebens- mittelzusatzstoffen im Einsatz sind. Hier seien beispielhaft die sogenannten Fruchtether genannt, aber auch andere Aromastoffe wie Ethylvanillin, 6-Methylcumarin, Citronellol oder auch Essigsäure-n-butyl-ester. Zusätze von oberflächenaktiven Substanzen können die Gleichmäßigkeit der Verteilung von Aromatröpfchen verbessern.Essences and flavors, which are used as additives for food and in pre-made food additives, occupy a very wide field. The so-called fruit ethers may be mentioned here by way of example, but also other flavorings such as ethylvanillin, 6-methylcoumarin, citronellol or also n-butyl acetate. Additions of surface-active substances can improve the uniformity of the distribution of aromatic droplets.
Es kann sich in besonderen Fällen als vorteilhaft erweisen, eine oder mehrere weitere Schichten gleicher oder unterschiedlicher Zusammensetzung aufzubringen, etwa um besondere Oberflächen- oder Zugeigenschaften zu erreichen.In special cases it can prove to be advantageous to apply one or more further layers of the same or different composition, for example in order to achieve special surface or tensile properties.
Die Masse wird zum Beispiel durch Einstreuen, Einkneten oder langsames Digerieren der festen Bestandteile im Lösungsmittel (in der Regel Wasser, aber auch z.B. Ethanol, Aceton und andere kompatible, physiologisch akzeptable Lösemittel und deren Gemische kommen zum Einsatz) erzeugt. In diese Phase werden, sofern rezepturmäßig enthalten, unter langsamen Rühren die vorgewogene Aromastoffmenge und andere flüssige, lipophile Zusatzstoffe hinzugeben. Es handelt sich im Interesse der Zielsetzung der Erfindung hinsichtlich einer gleichmäßigeren Beschaffenheit als sehr vorteilhaft erwiesen, die Masse vor Beschichtung über einen Schnellauflaufenden Homogenisator zu homogenisieren.The mass is obtained, for example, by sprinkling, kneading or slowly digesting the solid components in the solvent (usually water, but also, for example, ethanol, Acetone and other compatible, physiologically acceptable solvents and their mixtures are used). If contained in the recipe, the pre-weighed amount of flavoring and other liquid, lipophilic additives are added to this phase with slow stirring. In the interest of the objective of the invention, it has proven to be very advantageous with regard to a more uniform nature to homogenize the mass before coating via a high-speed homogenizer.
Im erfindungsgemäßen Prozeß wird die Masse durch Streich-, Rakel- oder Extrusionsverfahren auf ein Substrat beschichtet und in einem aus mindestens drei unabhängig temperierbaren Zonen bestehenden Trocknungskanal getrocknet. Das Substrat kann grundsätzlich aus dem Fachmann bekannten und weithin eingesetzten Substraten wie z.B. Polyethylen- terephthalat, Polyethylen, Polypropylen, Polycarbonat, Polyurethan bestehen. Zum Einsatz kommen auch Laminate dieser Stoffe mit anderen Polymeren, Papier, Glasfasern und sonstigen Strukturbildnern zur Erhöhung der Reißfestigkeit. Zur Regulierung der Oberflächenhaftung können Maßnahmen wie Siliconisierung, Fluorierung, Säurebehandlung oder Korona- Behandlung nützlich sein, bedürfen aber im einzelnen Fall einer Abklärung ihrer physiologischen Verträglichkeit für den jeweiligen Anwendungszweck.In the process according to the invention, the mass is coated onto a substrate by brushing, knife coating or extrusion processes and is dried in a drying channel consisting of at least three independently temperature-controlled zones. The substrate can in principle be made from substrates known to those skilled in the art and widely used, e.g. Polyethylene terephthalate, polyethylene, polypropylene, polycarbonate, polyurethane exist. Laminates of these materials with other polymers, paper, glass fibers and other structure formers are also used to increase the tear resistance. Measures such as siliconization, fluorination, acid treatment or corona treatment can be useful to regulate the surface adhesion, but in individual cases they need to be clarified as to their physiological compatibility for the respective application.
Besondere erfindungsgemäße Vorteile werden erreicht, wenn die der Beschichtungsmasse zugewandte Oberfläche keine glatte, sondern eine konturierte, mattierte, in jedem Fall oberflächenrauhe Kontur aufweist. Die Rauhtiefe kann im Bereich von 0,1 um bis ca. 10 um liegen, bevorzugt zwischen 0,5 und 3 um. Vorteilhaft sind in der mikroskopischen Feinstruktur rundliche Erhebungen, welche die Gleitreibung weiter verringern.Particular advantages according to the invention are achieved if the surface facing the coating composition does not have a smooth, but rather a contoured, matted, in any case rough surface contour. The roughness can be in the range from 0.1 µm to approximately 10 µm, preferably between 0.5 and 3 µm. Rounded elevations, which further reduce sliding friction, are advantageous in the microscopic fine structure.
Das erfindungsgemäße Ziel wird regelmäßig dann erreicht, wenn die Trocknung bei zunächst ansteigender, spätestens in der letzten Zone dann wieder um 10°C reduzierter Prozeßtemperatur verläuft .The aim of the invention is regularly achieved when the drying with initially increasing, at the latest in in the last zone then process temperature reduced by 10 ° C again.
Die Prozeßgeschwindigkeit ist vorteilhaft so einzustellen, daß ein Produkt mit einer Äquivalent-Luftfeuchte von 50-75% r.F., bevorzugt 60-68% r.F., erhalten wird.The process speed is advantageously set so that a product with an equivalent air humidity of 50-75% RH, preferably 60-68% RH, is obtained.
Die erhaltenen Produkte erwiesen sich unter diesen Prozeßbedingungen als flächenstabil, flexibel und bruchfest und weitgehend reißfest. Die entstandenen Oberflächen weisen so gut wie keinen "kalten Fluß" auf, sind also grundsätzlich formstabil. Die Folie läßt sich ohne merkliche Dehnung von der Unterlage abnehmen und separat weiterverarbeiten.Under these process conditions, the products obtained proved to be surface-stable, flexible and unbreakable and largely tear-resistant. The resulting surfaces have practically no "cold flow", so they are basically dimensionally stable. The film can be removed from the base without noticeable stretching and processed separately.
Die Äquivalent-Luftfeuchte wird folgendermaßen ermittelt: Ein frisch gefertigter Produktstreifen von ca. 0,1 ma Fläche wird mit Gummihandschuhen unmittelbar schnell gefaltet und in ein Weithals-Glasgefäß verbracht, dessen Deckel mit einer Durchbohrung so versehen ist, daß der Meßkopf eines Hygrometers eingeführt wird. Nach ca. einer Minute, je nach Gerätebauart, kann der Meßwert abgelesen werden.The equivalent air humidity is determined as follows: A freshly manufactured product strip of approx. 0.1 m a surface is quickly folded with rubber gloves and placed in a wide-necked glass vessel, the lid of which is drilled so that the measuring head of a hygrometer is inserted becomes. After approximately one minute, depending on the type of device, the measured value can be read off.
Die Weiterverarbeitung vollzieht sich nach Längsschnitt in Stanzeinrichtungen oder einfach durch Querschnitt . Die hergestellten folienförmigen Produkte weisen bevorzugt eine Dicke zwischen 20 und 300 um auf; ihre Größe kann vorteilhaft 0,5 bis 12 cm2 betragen. Die spätere Verpackung kann einzeln oder im Stapel beispielsweise in Siegelbeuteln oder Dosierspendern erfolgen. Further processing takes place after a longitudinal cut in punching devices or simply through a cross section. The film-shaped products produced preferably have a thickness between 20 and 300 μm; their size can advantageously be 0.5 to 12 cm 2 . The subsequent packaging can be done individually or in a stack, for example in sealed bags or dispensers.

Claims

A N S P R U C H E EXPECTATIONS
1. Verfahren zur Herstellung folienförmiger Darreichungsformen auf dem Wege der Beschichtung und Trocknung lösend.t- telhaltiger streichfähiger Masse auf einem Substrat, dadurch gekennzeichnet, daß die Trocknung in einer ersten Trocknungsphase zwischen 30 und 50°C, in einer zweiten Trocknungsphase zwischen 35 und 80°C und in einer dritten Trocknungsphase zwischen 25 und 50°C erfolgt.1. A process for the production of film-like dosage forms by coating and drying a solvent-containing, spreadable composition on a substrate, characterized in that the drying in a first drying phase between 30 and 50 ° C, in a second drying phase between 35 and 80 ° C and in a third drying phase between 25 and 50 ° C.
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß die Prozeßgeschwindigkeit so reguliert wird, daß eine relative Substratfeuchte von 50-75% r.F., bevorzugt 60-68 % r.F., nicht verlassen wird.2. The method according to claim 1, characterized in that the process speed is regulated so that a relative substrate moisture of 50-75% RH, preferably 60-68% RH, is not left.
3. Verfahren nach einem oder mehreren der vorangehenden Ansprüche, dadurch gekennzeichnet, daß das folienförmige Produkt Aromastoffe enthält.3. The method according to one or more of the preceding claims, characterized in that the film-shaped product contains flavorings.
4. Verfahren nach einem oder mehreren der vorangehenden Ansprüche, dadurch gekennzeichnet, daß das folienförmige Produkt als Hauptbestandteil Pullulan enthält.4. The method according to one or more of the preceding claims, characterized in that the film-shaped product contains pullulan as the main component.
5. Verfahren nach einem oder mehreren der vorangehenden Ansprüche, dadurch gekennzeichnet, daß die Trocknung des Laminates im ersten zeitlichen Drittel der Trocknungsphase zwischen 30 und 50°C, im zweiten Drittel zwischen 35 und 80 °C und im letzten Drittel zwischen 25 und 50°C liegt.5. The method according to one or more of the preceding claims, characterized in that the drying of the laminate in the first third of the drying phase between 30 and 50 ° C, in the second third between 35 and 80 ° C and in the last third between 25 and 50 ° C lies.
6. Verfahren nach einem oder mehreren der vorangehenden Ansprüche, dadurch gekennzeichnet, daß die Trocknung des folienförmigen Produkts auf einem oberflächenrauhen Material stattfindet. 6. The method according to one or more of the preceding claims, characterized in that the drying of the film-shaped product takes place on a surface-rough material.
7. Verfahren nach Anspruch 6, dadurch gekennzeichnet, daß als oberflächenrauhes Material ein polyethylenbeschichtetes Papier verwendet wird. 7. The method according to claim 6, characterized in that a polyethylene-coated paper is used as the surface-rough material.
PCT/EP2000/000739 1999-02-12 2000-01-31 Method for producing film-type dosage forms WO2000047190A2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
HU0202877A HUP0202877A2 (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms
NZ513465A NZ513465A (en) 1999-02-12 2000-01-31 Process for producing film-type dosage forms
AU31514/00A AU777898B2 (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms
MXPA01007867A MXPA01007867A (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms.
JP2000598143A JP2002536402A (en) 1999-02-12 2000-01-31 Method for producing sheet-form administration agent
IL14476700A IL144767A0 (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms
CA002362756A CA2362756C (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms
BRPI0009962-7A BR0009962B1 (en) 1999-02-12 2000-01-31 PROCESS FOR PRODUCTION OF BLADE FORMS FOR PRODUCT MINISTRY
EP00909123A EP1150663A2 (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms
IL144767A IL144767A (en) 1999-02-12 2001-08-07 Method for producing film-type dosage forms
NO20013892A NO20013892L (en) 1999-02-12 2001-08-09 Process for preparing foil-shaped administration forms
HK02100760.6A HK1039069A1 (en) 1999-02-12 2002-01-31 Method for producing film-type dosage forms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19905801A DE19905801B4 (en) 1999-02-12 1999-02-12 Process for the preparation of film-shaped dosage forms
DE19905801.6 1999-02-12

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09913089 A-371-Of-International 2001-08-27
US10/314,549 Continuation US6800329B2 (en) 1999-02-12 2002-12-09 Method for producing film-type dosage

Publications (2)

Publication Number Publication Date
WO2000047190A2 true WO2000047190A2 (en) 2000-08-17
WO2000047190A3 WO2000047190A3 (en) 2000-12-14

Family

ID=7897244

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/000739 WO2000047190A2 (en) 1999-02-12 2000-01-31 Method for producing film-type dosage forms

Country Status (22)

Country Link
EP (1) EP1150663A2 (en)
JP (1) JP2002536402A (en)
KR (1) KR100620068B1 (en)
CN (1) CN1147293C (en)
AR (1) AR022580A1 (en)
AU (1) AU777898B2 (en)
BR (1) BR0009962B1 (en)
CA (1) CA2362756C (en)
CZ (1) CZ301872B6 (en)
DE (1) DE19905801B4 (en)
HK (1) HK1039069A1 (en)
HU (1) HUP0202877A2 (en)
IL (2) IL144767A0 (en)
MX (1) MXPA01007867A (en)
NO (1) NO20013892L (en)
NZ (1) NZ513465A (en)
PL (1) PL202678B1 (en)
RU (1) RU2226389C2 (en)
TR (1) TR200102056T2 (en)
TW (1) TWI254725B (en)
WO (1) WO2000047190A2 (en)
ZA (1) ZA200106580B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005513140A (en) * 2001-12-11 2005-05-12 セアプロ インク Cereal β-glucan composition, preparation method and use thereof
US10568839B2 (en) 2011-01-11 2020-02-25 Capsugel Belgium Nv Hard capsules
US11319566B2 (en) 2017-04-14 2022-05-03 Capsugel Belgium Nv Process for making pullulan
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10114509A1 (en) * 2001-03-23 2002-10-02 Haarmann & Reimer Gmbh Production of encapsulated product fixed to surface, by applying mixture of film-forming polymer, core material (especially fragrance or aroma) and organic solvent to surface and drying

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456745A (en) * 1988-08-13 1995-10-10 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Flexible, hydrophilic gel film, the process for its production and the use of it
WO1995029664A1 (en) * 1994-05-03 1995-11-09 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
WO1998026764A1 (en) * 1996-12-16 1998-06-25 Lts Lohmann Therapie-Systeme Gmbh Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6055039A (en) * 1983-09-07 1985-03-29 Mitsubishi Acetate Co Ltd Water-soluble polysaccharide film
DE3333240A1 (en) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen MEDIUM FOR TRANSDERMAL APPLICATION OF MEDICINAL PRODUCTS
JPH0744940B2 (en) * 1986-12-24 1995-05-17 ライオン株式会社 Base material for oral application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456745A (en) * 1988-08-13 1995-10-10 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Flexible, hydrophilic gel film, the process for its production and the use of it
WO1995029664A1 (en) * 1994-05-03 1995-11-09 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
WO1998026764A1 (en) * 1996-12-16 1998-06-25 Lts Lohmann Therapie-Systeme Gmbh Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005513140A (en) * 2001-12-11 2005-05-12 セアプロ インク Cereal β-glucan composition, preparation method and use thereof
US8632798B2 (en) 2001-12-11 2014-01-21 Ceapro Inc. Cereal β glucan compositions, methods of preparation and uses thereof
US10568839B2 (en) 2011-01-11 2020-02-25 Capsugel Belgium Nv Hard capsules
US11319566B2 (en) 2017-04-14 2022-05-03 Capsugel Belgium Nv Process for making pullulan
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules
US11878079B2 (en) 2017-04-14 2024-01-23 Capsugel Belgium Nv Pullulan capsules

Also Published As

Publication number Publication date
HK1039069A1 (en) 2002-04-12
ZA200106580B (en) 2002-02-14
CN1336820A (en) 2002-02-20
TR200102056T2 (en) 2001-11-21
IL144767A (en) 2006-08-20
JP2002536402A (en) 2002-10-29
NO20013892D0 (en) 2001-08-09
DE19905801A1 (en) 2000-08-17
AU3151400A (en) 2000-08-29
KR100620068B1 (en) 2006-09-05
KR20010102050A (en) 2001-11-15
AU777898B2 (en) 2004-11-04
PL349857A1 (en) 2002-09-23
CZ20012900A3 (en) 2002-01-16
CA2362756C (en) 2009-11-24
AR022580A1 (en) 2002-09-04
CA2362756A1 (en) 2000-08-17
MXPA01007867A (en) 2002-07-02
CZ301872B6 (en) 2010-07-14
TWI254725B (en) 2006-05-11
IL144767A0 (en) 2002-06-30
DE19905801B4 (en) 2008-03-13
NO20013892L (en) 2001-08-09
PL202678B1 (en) 2009-07-31
EP1150663A2 (en) 2001-11-07
NZ513465A (en) 2003-05-30
RU2226389C2 (en) 2004-04-10
HUP0202877A2 (en) 2003-03-28
BR0009962A (en) 2002-04-16
BR0009962B1 (en) 2014-07-29
CN1147293C (en) 2004-04-28
WO2000047190A3 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
US6800329B2 (en) Method for producing film-type dosage
EP0460588B1 (en) Manufacture process of fast-desintegrating film-formed administration forms
EP0949909B1 (en) Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
EP0766556B1 (en) Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use
DE19646392A1 (en) Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
DE2012775C3 (en) Ointment foils and process for their manufacture
DE69915831T2 (en) FILM COATINGS WITH TARGETED WETTABILITY OPENINGS AND METHOD AND PRODUCTION THEREOF
EP1634587B1 (en) Film preparation for biphasic release of pharmacologically active or other substances
EP0439180A2 (en) Therapeutic transdermal system containing tulobuterol as the active ingredient
WO1994008571A2 (en) Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same
DE2356098C3 (en) Composition for envelopes
DE19905801B4 (en) Process for the preparation of film-shaped dosage forms
EP1087759B1 (en) Method for manufacturing a laminate consisting of individual layers
US20040126497A1 (en) Method for producing film-type dosage
DE102004049740A1 (en) Self-adhesive tooth foil
DE19702314A1 (en) Removable protective film for active substance-containing, in particular self-adhesive, plaster systems
WO2024017639A1 (en) Release coating with low friction coefficient
DE19728279A1 (en) Ketoprofen plaster with long-term and immediate effect,
WO2020083413A1 (en) Lipophilic transport particles for cosmetic or pharmaceutical active ingredients
EP3870144A1 (en) Lipophilic transport particles for cosmetic or pharmaceutical active ingredients

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00802865.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN CZ HU IL IN JP KR MX NO NZ PL RU TR US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN CZ HU IL IN JP KR MX NO NZ PL RU TR US ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2000909123

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 31514/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001/02056

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 2000 598143

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/007867

Country of ref document: MX

Ref document number: IN/PCT/2001/00690/DE

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 144767

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 513465

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PV2001-2900

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2362756

Country of ref document: CA

Ref document number: 2362756

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001/06580

Country of ref document: ZA

Ref document number: 1020017010143

Country of ref document: KR

Ref document number: 200106580

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 09913089

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000909123

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020017010143

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: PV2001-2900

Country of ref document: CZ

CFP Corrected version of a pamphlet front page

Free format text: UNDER (57) PUBLISHED ABSTRACT IN ENGLISH REPLACED BY CORRECT ABSTRACT

WWG Wipo information: grant in national office

Ref document number: 31514/00

Country of ref document: AU

WWR Wipo information: refused in national office

Ref document number: 1020017010143

Country of ref document: KR